NCT06975553

Brief Summary

The goal of this clinical trial is to evaluate whether extubation guided by the Integrated Pulmonary Index (IPI)-a composite respiratory score derived from microstream sidestream end-tidal carbon dioxide (EtCO₂) monitoring-improves safety in adults recovering from general anesthesia in the Post-Anesthesia Care Unit (PACU). It will also assess adverse events associated with IPI-guided extubation. The main questions it aims to answer are:

  1. 1.Does IPI-guided extubation reduce the incidence of hypoxemia compared to conventional methods?
  2. 2.What adverse events (e.g., cardiovascular complications, prolonged hypoxemia) occur with IPI-guided extubation? Researchers will compare the IPI-guided group (extubated when IPI ≥8) to the conventional group (extubated per standard PACU protocols) to determine if IPI monitoring improves extubation outcomes.
  3. 3.Group T (IPI-guided): Receive continuous EtCO₂/IPI monitoring via an endotracheal sampling line, with extubation triggered when IPI ≥8 after spontaneous respiration resumes.
  4. 4.Group C (Conventional): Follow standard PACU extubation protocols without IPI monitoring.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
632

participants targeted

Target at P75+ for not_applicable

Timeline
5mo left

Started Jun 2025

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress68%
Jun 2025Sep 2026

First Submitted

Initial submission to the registry

April 29, 2025

Completed
17 days until next milestone

First Posted

Study publicly available on registry

May 16, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

June 30, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2026

Last Updated

January 27, 2026

Status Verified

April 1, 2025

Enrollment Period

1 year

First QC Date

April 29, 2025

Last Update Submit

January 24, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Incidence of hypoxemia

    The incidence of hypoxemia in each group(%).

    immediately after extubation, 5 minutes after extubation, 10 minutes after extubation

  • Duration of hypoxemia

    Duration of hypoxemia(seconds)

    From extubation to discharge from the PACU.

Secondary Outcomes (2)

  • Incidence of subclinical hypoxemia

    immediately after extubation, 5 minutes after extubation, 10 minutes after extubation

  • Duration of subclinical hypoxemia

    From extubation to discharge from the PACU.

Study Arms (2)

Group C

NO INTERVENTION

Group C:the conventional extubation group

Group T

EXPERIMENTAL

Group T:extubation group with IPI monitoring

Device: endotracheal intubation-type end-tidal carbon dioxide sampling tube

Interventions

In addition to routine monitoring (ECG, NIBP, and SpO2), an endotracheal intubation-type end-tidal carbon dioxide sampling tube is used for end-tidal carbon dioxide IPI monitoring.

Group T

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 18 years and above and under 80 years old, with ASA classification of I - III, who received general anesthesia and tracheal intubation at the anesthesia recovery unit (PACU) of multiple centers such as the First Medical Center of the Chinese People's Liberation Army General Hospital, and planned for elective abdominal surgery (including digestive system surgeries in general surgery, gynecological surgeries, hepatobiliary surgeries, or urological surgeries), with a surgery duration of 1 hour or more and less than 4 hours, during the period from April 2025 to April 2026.
  • Have signed the informed consent form.

You may not qualify if:

  • Patients whose tracheal intubation was removed before entering the anesthesia recovery room.
  • Patients with preoperative indoor air oxygen saturation (SpO₂) lower than 95%, or those who failed to enter the anesthesia recovery room due to any reason after surgery.
  • Patients with a history of sleep apnea.
  • Patients who have undergone two surgeries within one month.
  • Patients with a history of neuromuscular dysfunction.
  • Patients with mental or cognitive disorders; those with a history of abuse of psychotropic or anesthetic drugs; or those with communication disorders.
  • Patients who cannot cooperate with the clinical trial.
  • Patients who developed severe arrhythmia after entering the anesthesia recovery room.
  • Patients who were delayed in extubation after entering the anesthesia recovery room due to medical conditions (such as waiting for frozen section results, experiencing massive bleeding, etc.).
  • Patients who required another surgery after extubation in the anesthesia recovery room.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medtronic 20p

Beijing, Beijing Municipality, China

Location

Related Publications (3)

  • Potvin J, Etchebarne I, Soubiron L, Biais M, Roullet S, Nouette-Gaulain K. Effects of capnometry monitoring during recovery in the post-anaesthesia care unit: a randomized controlled trial in adults (CAPNOSSPI). J Clin Monit Comput. 2022 Apr;36(2):379-385. doi: 10.1007/s10877-021-00661-9. Epub 2021 Feb 7.

    PMID: 33550546BACKGROUND
  • Laporta ML, Sprung J, Weingarten TN. Respiratory depression in the post-anesthesia care unit: Mayo Clinic experience. Bosn J Basic Med Sci. 2021 Apr 1;21(2):221-228. doi: 10.17305/bjbms.2020.4816.

    PMID: 32415817BACKGROUND
  • Bartels K, Kaizer A, Jameson L, Bullard K, Dingmann C, Fernandez-Bustamante A. Hypoxemia Within the First 3 Postoperative Days Is Associated With Increased 1-Year Postoperative Mortality After Adjusting for Perioperative Opioids and Other Confounders. Anesth Analg. 2020 Aug;131(2):555-563. doi: 10.1213/ANE.0000000000004553.

MeSH Terms

Conditions

Hypoxia

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Pei qi wang

    The Firsst Medical Center ,Chinese PLA General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

April 29, 2025

First Posted

May 16, 2025

Study Start

June 30, 2025

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

September 30, 2026

Last Updated

January 27, 2026

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations